MY BODY MY PROJECT
Weight-loss medications are now everywhere, and using them to optimize the body feels like the responsible thing to do. This shift to shed unwanted kilos pushes against the self-acceptance once championed by the body positivity movement, and reframes self-optimization as a more fitting form of self-love.
→ With one in eight U.S. adults on weight-loss drugs by 2025, the 2026 arrival of a pill form opens the floodgates to even broader audiences.
→ U.S. airlines are expected to reduce fuel consumption due to lower passenger weights.
→ GLP-1 users are reshaping the food industry through their curbed appetites, but they also exhibit a higher willingness to pay for high-protein products to optimize their diets.
→ While GLP-1 medications heighten body confidence, shifts in desire, arousal, dryness, and orgasmic function create opportunities in the sexual wellness space as users optimize their bodies for pleasure.
Pockets of the Future
Explore where this signal is already showing up
Less sugar, more protein: 21% of US households now include a GLP-1 user, and 61% of users buy fewer sweets, while 35% buy more packaged protein.
Source: PWC: ‘The end of more: How GLP-1 users shop, eat, and seek support,’ June 2026
Wellness without silos: market researcher NielsenIQ ties GLP-1s and sexual wellness together as twin forces reshaping women’s health.
Source: NIQ: ‘Re-Imagining Women’s Wellness: From GLP-1s to Sexual Wellness,’ Dec 2025
Lighter loads: a Wall Street analysis estimates the four biggest US airlines could save up to $580 million a year on fuel as weight-loss drugs make passengers lighter.
Source: West Hawaii Today: ‘Weight-loss drugs could save US airlines $580 million per year,’ Jan 2026
The pill that opened the floodgates: the Wegovy pill passed 3 million US prescriptions within five months of its January 2026 launch, and over 80% went to people new to GLP-1s.
Image: New York Times